Qing Jia1, Michael J Brown1, Leanne Clifford1, Gregory A Wilson1, Mark J Truty2, James R Stubbs3, Darrell R Schroeder4, Andrew C Hanson4, Ognjen Gajic5, Daryl J Kor6. 1. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA. 2. Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. 3. Division of Transfusion Medicine, Mayo Clinic, Rochester, MN, USA. 4. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. 5. Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA; Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN, USA. 6. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA. Electronic address: kor.daryl@mayo.edu.
Abstract
BACKGROUND: Perioperative haemorrhage negatively affects patient outcomes and results in substantial consumption of health-care resources. Plasma transfusions are often administered to address abnormal preoperative coagulation tests, with the hope to mitigate bleeding complications. We aimed to assess the associations between preoperative plasma transfusion and bleeding complications in patients with elevated international normalised ratio (INR) undergoing non-cardiac surgery. METHODS: We did an observational study in a consecutive sample of adult patients undergoing non-cardiac surgery with preoperative INR greater than or equal to 1·5. The exposure of interest was transfusion of preoperative plasma for elevated INR. The primary outcome was WHO grade 3 bleeding in the early perioperative period (from entry into the operating room until 24 h following exit from operating room). Hypotheses were tested with univariate and propensity-matched analyses. We did multiple sensitivity analyses to further evaluate the robustness of study findings. FINDINGS: Between Jan 1, 2008, and Dec 31, 2011, we identified 1234 (8·4%) of 14 743 patients who had an INR of 1·5 or above and were included in this investigation. Of 1234 study participants, 139 (11%) received a preoperative plasma transfusion. WHO grade 3 bleeding occurred in 73 (53%) of 139 patients who received preoperative plasma compared with 350 (32%) of 1095 patients who did not (odds ratio [OR] 2·35, 95% CI 1·65-3·36; p<0·0001). Among the propensity-matched cohort, 65 (52%) of 125 plasma recipients had WHO grade 3 bleeding compared with 97 (40%) of 242 of those who did not receive preoperative plasma (OR 1·75, 95% CI 1·09-2·81; p=0·021). Results from multiple sensitivity analyses were qualitatively similar. INTERPRETATION: Preoperative plasma transfusion for elevated international normalised ratios was associated with an increased frequency of perioperative bleeding complications. Findings were robust in the sensitivity analyses, suggestive that more conservative management of abnormal preoperative international normalised ratios is warranted. FUNDING: Mayo Clinic, National Institutes of Health.
BACKGROUND: Perioperative haemorrhage negatively affects patient outcomes and results in substantial consumption of health-care resources. Plasma transfusions are often administered to address abnormal preoperative coagulation tests, with the hope to mitigate bleeding complications. We aimed to assess the associations between preoperative plasma transfusion and bleeding complications in patients with elevated international normalised ratio (INR) undergoing non-cardiac surgery. METHODS: We did an observational study in a consecutive sample of adult patients undergoing non-cardiac surgery with preoperative INR greater than or equal to 1·5. The exposure of interest was transfusion of preoperative plasma for elevated INR. The primary outcome was WHO grade 3 bleeding in the early perioperative period (from entry into the operating room until 24 h following exit from operating room). Hypotheses were tested with univariate and propensity-matched analyses. We did multiple sensitivity analyses to further evaluate the robustness of study findings. FINDINGS: Between Jan 1, 2008, and Dec 31, 2011, we identified 1234 (8·4%) of 14 743 patients who had an INR of 1·5 or above and were included in this investigation. Of 1234 study participants, 139 (11%) received a preoperative plasma transfusion. WHO grade 3 bleeding occurred in 73 (53%) of 139 patients who received preoperative plasma compared with 350 (32%) of 1095 patients who did not (odds ratio [OR] 2·35, 95% CI 1·65-3·36; p<0·0001). Among the propensity-matched cohort, 65 (52%) of 125 plasma recipients had WHO grade 3 bleeding compared with 97 (40%) of 242 of those who did not receive preoperative plasma (OR 1·75, 95% CI 1·09-2·81; p=0·021). Results from multiple sensitivity analyses were qualitatively similar. INTERPRETATION: Preoperative plasma transfusion for elevated international normalised ratios was associated with an increased frequency of perioperative bleeding complications. Findings were robust in the sensitivity analyses, suggestive that more conservative management of abnormal preoperative international normalised ratios is warranted. FUNDING: Mayo Clinic, National Institutes of Health.
Authors: Anne F Eder; Ross M Herron; Annie Strupp; Beth Dy; Jenni White; Edward P Notari; Roger Y Dodd; Richard J Benjamin Journal: Transfusion Date: 2010-04-30 Impact factor: 3.157
Authors: Patrick C Malloy; Clement J Grassi; Sanjoy Kundu; Debra Ann Gervais; Donald L Miller; Robert B Osnis; Darren W Postoak; Dheeraj K Rajan; David Sacks; Marc S Schwartzberg; Darryl A Zuckerman; John F Cardella Journal: J Vasc Interv Radiol Date: 2009-04-25 Impact factor: 3.464
Authors: Aryeh Shander; Axel Hofmann; Sherri Ozawa; Oliver M Theusinger; Hans Gombotz; Donat R Spahn Journal: Transfusion Date: 2009-12-09 Impact factor: 3.157
Authors: Ian Welsby; Jennifer Crow; Nicholas Bandarenko; George Lappas; Barbara Phillips-Bute; Mark Stafford-Smith Journal: Transfusion Date: 2010-11 Impact factor: 3.157
Authors: Anas Alsara; David O Warner; Guangxi Li; Vitaly Herasevich; Ognjen Gajic; Daryl J Kor Journal: Mayo Clin Proc Date: 2011-05 Impact factor: 7.616
Authors: Simon J Stanworth; John Grant-Casey; Derek Lowe; Mike Laffan; Helen New; Mike F Murphy; Shubha Allard Journal: Transfusion Date: 2010-08-27 Impact factor: 3.157
Authors: Timothy S Walsh; Simon J Stanworth; Robin J Prescott; Robert J Lee; Douglas M Watson; Duncan Wyncoll Journal: Crit Care Med Date: 2010-10 Impact factor: 7.598
Authors: Lena M Napolitano; Stanley Kurek; Fred A Luchette; Howard L Corwin; Philip S Barie; Samuel A Tisherman; Paul C Hebert; Gary L Anderson; Michael R Bard; William Bromberg; William C Chiu; Mark D Cipolle; Keith D Clancy; Lawrence Diebel; William S Hoff; K Michael Hughes; Imtiaz Munshi; Donna Nayduch; Rovinder Sandhu; Jay A Yelon Journal: Crit Care Med Date: 2009-12 Impact factor: 7.598
Authors: Michael C Christensen; Stephan Krapf; Angela Kempel; Christian von Heymann Journal: J Thorac Cardiovasc Surg Date: 2009-04-19 Impact factor: 5.209
Authors: Che Ngufor; Matthew A Warner; Dennis H Murphree; Hongfang Liu; Rickey Carter; Curtis B Storlie; Daryl J Kor Journal: AMIA Annu Symp Proc Date: 2018-04-16
Authors: Matthew A Warner; Ryan D Frank; Timothy J Weister; Mark M Smith; James R Stubbs; Daryl J Kor Journal: Transfusion Date: 2018-11-01 Impact factor: 3.157
Authors: James Neuberger; Jai Patel; Helen Caldwell; Susan Davies; Vanessa Hebditch; Coral Hollywood; Stefan Hubscher; Salil Karkhanis; Will Lester; Nicholas Roslund; Rebecca West; Judith I Wyatt; Mathis Heydtmann Journal: Gut Date: 2020-05-28 Impact factor: 23.059